Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Pulmonx | LUNG | Nov 20, 2024 | 6.20 | +3.33 |
Pulse Biosciences | PLSE | Nov 20, 2024 | 16.14 | -5.28 |
PulteGroup | PHM | Nov 20, 2024 | 128.06 | -0.35 |
Puma Biotechnology | PBYI | Nov 20, 2024 | 2.84 | +3.65 |
Pure Cycle | PCYO | Nov 20, 2024 | 13.10 | -1.21 |
Pure Storage A | PSTG | Nov 20, 2024 | 49.78 | -0.24 |
PureCycle Technologies | PCT | Nov 20, 2024 | 11.99 | +2.74 |
PureCycle Technologies Unit | PCTTU | Nov 20, 2024 | 14.60 | 0.00 |
Purefunds ISE Junior Silver [Sm | SILJ | Nov 20, 2024 | 12.01 | -2.20 |
PureTech Health ADR | PRTC | Nov 20, 2024 | 21.70 | +2.06 |
Purple Biotech ADR | PPBT | Nov 20, 2024 | 2.47 | -5.73 |
Purple Innovation | PRPL | Nov 20, 2024 | 0.83 | -2.48 |
Putnam Managed Municipal Income Trust | PMM | Nov 20, 2024 | 6.17 | +0.33 |
Putnam Master Intermediate Income Trust | PIM | Nov 20, 2024 | 3.23 | -0.15 |
Putnam Municipal Opportunities Trust | PMO | Nov 20, 2024 | 10.39 | +0.10 |
Putnam Premier Income Trust | PPT | Nov 20, 2024 | 3.54 | +0.28 |
PVH | PVH | Nov 20, 2024 | 96.47 | -2.22 |
Pyrophyte Acquisition | PHYT | Nov 20, 2024 | 11.55 | 0.00 |
Pyxis Oncology | PYXS | Nov 20, 2024 | 3.82 | -8.17 |
Pyxis Tankers | PXS | Nov 20, 2024 | 4.15 | +0.85 |
Pyxis Tankers Pref | PXSAP | Nov 20, 2024 | 24.97 | 0.00 |
Q2 | QTWO | Nov 20, 2024 | 101.44 | +1.84 |
Q32 Bio | QTTB | Nov 20, 2024 | 27.28 | -6.22 |
QCR | QCRH | Nov 20, 2024 | 89.31 | +0.02 |
QIAGEN | QGEN | Nov 20, 2024 | 42.09 | +3.16 |
Qifu Technology ADR | QFIN | Nov 20, 2024 | 35.25 | +8.91 |
QMMM | QMMM | Nov 20, 2024 | 0.71 | -43.94 |
Qomolangma Acquisition | QOMO | Nov 20, 2024 | 11.55 | 0.00 |
Qorvo | QRVO | Nov 20, 2024 | 65.66 | -0.94 |
QT Imaging | QTI | Nov 20, 2024 | 0.57 | +0.85 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.